Tranzyme, Quark Biotech Pen Licensing, R&D Collaboration

genomeweb
360dx

Tranzyme, Quark Biotech Pen Licensing, R&D Collaboration

May 15, 2002

NEW YORK, May 15 - Tranzyme and Quark Biotech have inked a multi-year research and licensing collaboration, Tranzyme said today.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Fabric Genomics, Genomenon Sign Co-Marketing Deal
Healthy Esophageal Tissue Often Marked by Cancer-Related Mutations
Secondary Glioblastoma Genomics Study Leads to Proposed Treatment Target
DiaSorin Receives CE Mark for Simplexa Group B Strep Assay
Co-Diagnostics Receives CE-IVD Marking for Zika Test
Cancer Genetics, GeneCast Ink Cancer Test Distribution Deal

The Scan

Breakthrough Prize Winners Announced

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

Misuse of Genetic Research

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Not Quite the Ivy League Gene

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

This Week in Nature

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.

Main menu